Recce Pharmaceuticals (RCE.AU) Q1 2024 Earnings

26FebConfirmed
Oct 22
Q4 2022
Q2 2023
Q1 2024
-0.04
0.29
0.62
0.96

Details

Expected EPS
N/A
Actual EPS
-0.04330677946816
Surprise EPS
-0.04
Surprise Percent
+∞%

Description

Recce Pharmaceuticals (RCE.AU) has reported earnings of -0.04330677946816 per share for Q1 2024.

0 Comments

Share your thoughts